Daily Newsletter

04 September 2023

Daily Newsletter

04 September 2023

Jupiter Hospitals IPO to open for subscription on 6 September

The offering will end on 8 September, with anchor investor bidding commencing on 5 September.

September 01 2023

The IPO of Indian multispecialty hospital chain Jupiter Life Line Hospitals is set to open for subscription on 6 September.

This offering will end on 8 September, with anchor investor bidding commencing on 5 September.

The IPO includes a fresh equity share issue of Rs5.42bn ($65.61m) and an offer for sale (OFS) of 4.45 million equity shares by promoter group entities and other shareholders.

As part of the OFS, Devang Vasantlal Gandhi intends to sell a maximum of 1.25 million equity shares, while Devang Gandhi, along with Neeta Gandhi, plans to collectively offload 0.9 million equity shares.

Recently, Jupiter Hospitals secured Rs1.23bn ($14.89m) from institutional investors during the pre-IPO round, leading to a subsequent reduction in the size of the fresh issue.

The funds raised from the IPO will be used to retire debt and for general corporate purposes.

Jupiter Hospital operates under the Jupiter brand in Thane, Pune, and Indore cities, with a total bed capacity of 1,194 as of December 2022.

Besides, the company is developing a multispecialty hospital in Dombivli, Maharashtra, designed to accommodate over 500 beds.

ICICI Securities, Edelweiss Financial Services, and JM Financial are the lead managers for the IPO, and the equity shares are planned to be listed on the BSE and NSE stock exchanges.

Medical robotics set to witness robust growth in the next decade

GlobalData expects every segment of the medical robotics market to grow over the next decade, driven by the demands of high-volume procedures. Per GlobalData forecasts, the surgical robotics market is expected to grow at a CAGR of 8% by 2030. Surgical robots improve patient outcomes, reduce human error, and decrease the length of hospital stays. New surgical robot models will offer new surgical possibilities, such as micro-robots to address difficult-to-treat diseases.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close